Francis Kalemeera
Francis Kalemeera publishes mostly in Infectious Diseases, Economics and Econometrics and Applied Microbiology and Biotechnology, on topics such as HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions and Pharmaceutical Economics and Policy.
- World rank
- #1,256,328 of 7,710,434 ranked researchers
- Rank in Namibia
- #29 of 381
- Works
- 49
- Citations
- 1.4k
- Citations per work
- 28.9
What does Francis Kalemeera research?
Francis Kalemeera's work is mostly in Medicine (39%), Economics, Econometrics and Finance (12%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2243.9%
- Health Sciences1938.6%
- Medicine1938.6%
- Social Sciences611.7%
- Life Sciences35.8%
- 1Infectious Diseases22% of their works
- 2Economics and Econometrics12% of their works
- 3Applied Microbiology and Biotechnology6% of their works
- 4Public Health, Environmental and Occupational Health6% of their works
- 5Endocrinology, Diabetes and Metabolism6% of their works
- 6Emergency Medicine5% of their works
Research topics
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Pharmaceutical Economics and Policy
- Antibiotic Use and Resistance
- HIV-related health complications and treatments
- Biosimilars and Bioanalytical Methods
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Practices and Patient Outcomes
Which keywords describe Francis Kalemeera's research?
The keywords of their largest research topics: Antiretroviral Therapy, Drug Resistance, HIV Infection, Integrase Inhibitors, Nucleoside Analogues, HIV Transmission, Preexposure Prophylaxis and Drug Development Costs.
- Inappropriate Medication Use
- Immunogenicity
- Biosimilars
- Cardiovascular Disease
- Antibiotic Resistance
- Drug Development Costs
- HIV Transmission
- Integrase Inhibitors
- Drug Resistance
- Antiretroviral Therapy
- HIV Infection
- Nucleoside Analogues
- Preexposure Prophylaxis
- Generic Drugs
- Antimicrobial Stewardship
- Inflammation
- Cost-effectiveness Analysis
- Quality of Life
- Polypharmacy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antiretroviral Therapy303 topics
- Drug Resistance202 topics
- HIV Infection192 topics
- Integrase Inhibitors121 topic
- Nucleoside Analogues121 topic
- HIV Transmission111 topic
- Preexposure Prophylaxis111 topic
- Drug Development Costs101 topic
- Generic Drugs101 topic
- Antibiotic Resistance81 topic
- Antimicrobial Stewardship81 topic
- Cardiovascular Disease71 topic
- Inflammation71 topic
- Biosimilars51 topic
- Cost-effectiveness Analysis51 topic
- Immunogenicity51 topic
- Quality of Life51 topic
- Inappropriate Medication Use41 topic
- Polypharmacy41 topic
Where does Francis Kalemeera work?
Francis Kalemeera's main affiliation in the publication record is University of Namibia, Namibia.
How many publications and citations does Francis Kalemeera have?
OpenAlex counts 49 works and 1,417 citations for Francis Kalemeera, an h-index of 17, ranking #1,256,328 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Francis Kalemeera. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.